Hereditary angioedema (HAE) is an autosomal dominant hereditary disorder characterized by episodic swelling of many body regions (especially throat and abdomen), potentially triggered by medication. No data are available for HAE in patients with cancer assigned to standard chemotherapy. The aim of our study was to identify circulating mediators potentially predictive of acute HAE attacks during chemotherapy.
Morelli, C., Formica, V., Pellicori, S., Menghi, A., Guarino, M.d., Perricone, R., et al. (2018). Chemotherapy in patients with hereditary angioedema. ANTICANCER RESEARCH, 38(12), 6801-6807 [10.21873/anticanres.13052].
Chemotherapy in patients with hereditary angioedema
Formica V.;Guarino M. D.;Perricone R.;Roselli M.
2018-01-01
Abstract
Hereditary angioedema (HAE) is an autosomal dominant hereditary disorder characterized by episodic swelling of many body regions (especially throat and abdomen), potentially triggered by medication. No data are available for HAE in patients with cancer assigned to standard chemotherapy. The aim of our study was to identify circulating mediators potentially predictive of acute HAE attacks during chemotherapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
